FIELD: medicine.
SUBSTANCE: for treatment of left ventricle hypertrophy (HLV) in patients with coronary disease in combination with hypertension during 6 months standard drug therapy, consisting of IATA, beta-blocker, aspirin and stanin is realised. Additionally ivabradin in day dose 5 - 15 mg is introduced in two intakes daily.
EFFECT: method ensures transformation of HLV in concentric remodeling of left ventricle and in such way reduces degree of cardiovascular complications risk.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR LEFT VENTRICULAR HYPERTROPHY CORRECTION IN ELDERLY AND SENILE PATIENTS WITH ARTERIAL HYPERTENSION | 2014 |
|
RU2568902C2 |
| METHOD OF CORRECTING KIDNEY MALFUNCTION IN PATIENTS WITH STABLE STENOCARDIA IN COMBINATION WITH HYPERTENSION | 2010 |
|
RU2425671C1 |
| METHOD OF VASCULAR REMODELLING CORRECTION IN PATIENTS SUFFERING FROM CHRONIC ISCHEMIC CARDIAC INSUFFICIENCY | 2008 |
|
RU2364401C1 |
| METHOD OF DRUG TREATMENT OF PATIENTS IN LATE REHABILITATION PERIOD AFTER AORTOCORONARY BYPASS SURGERY | 2013 |
|
RU2545985C2 |
| METHOD OF INCREASING EFFICIENCY OF SHORT-TERM AND MIDDLE-TERM ANTIHYPERTENSIVE THERAPY AND REDUCTION OF LEFT VENTRUCLE HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-ND PHASE OF 2-ND DEGREE OF RISK 3 | 2011 |
|
RU2463043C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
| METHOD OF TREATING ISCHEMIC HEART DISEASES ACCOMPANYING CHOLESTASIS | 2014 |
|
RU2554333C1 |
| METHOD FOR PREDICTING AN INCREASE IN LEFT VENTRICULAR EJECTION FRACTION 12 MONTHS AFTER CORONARY BYPASS SURGERY IN PATIENTS WITH HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION | 2022 |
|
RU2793656C1 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| THERAPEUTIC APPROACH TO PATIENTS SUFFERING ISCHEMIA OF LOWER EXTREMITIES AND MULTIVESSEL DISEASE OF CORONARY BED | 2014 |
|
RU2553429C1 |
